Global: CRISPR-Edited Starch Potatoes Promise Functional Gains Without Transgenes
Gene-edited potatoes with modified starch composition are moving through development, offering processing and health benefits under lighter regulation than GMOs in some markets.
CRISPR-edited potato lines with modified starch — higher amylopectin for processing or altered digestibility for health positioning — are advancing through development pipelines, with transgene-free lines selectable from editing programs.
The regulatory distinction matters: several jurisdictions treat gene edits that mimic conventional mutations differently from transgenic GMOs, potentially shortening approval timelines and easing consumer acceptance.
For processors, edited starch profiles could improve texture stability in frozen products and tailor starch behavior for specific industrial applications.
Weekdays. Unsubscribe in one click.
Breeding programs emphasize that editing accelerates but does not replace conventional breeding: edited traits must still be combined with yield, disease resistance and agronomic performance through standard crossing and selection.
In the EU, the new genomic techniques rules were adopted as Regulation (EU) 2026/1388 and apply from July 2028: Category 1 plants will be treated like conventional varieties, while Category 2 plants remain under GMO rules.
Sources: European Commission — New genomic techniques; GMP+ International, 2026; Andersson et al., Plant Cell Reports, 2017 (SLU)
